Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta‐analysis of randomized double‐blind controlled trials

Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a... Aims The aim of this study was to assess the evidence on the effect of oral magnesium supplementation on glycaemic control in patients with Type 2 diabetes. Methods We searched the electronic databases of medline, embase and the Cochrane Controlled Trials Register up to January 2005. We identified nine randomized double‐blind controlled trials with a total of 370 patients with Type 2 diabetes and of duration 4–16 weeks. The median dose of oral magnesium supplementation was 15 mmol/day (360 mg/day) in the treatment groups. The primary outcome was glycaemic control, as measured by glycated haemoglobin (HbA1c) or fasting blood glucose levels; the secondary outcomes included body mass index, blood pressure (BP) and lipids. Using a random‐effects model, we calculated the weighted mean differences (WMD) and 95% confidence interval (CI). Results After a median duration of 12 weeks, the weighted mean post‐intervention fasting glucose was significantly lower in the treatment groups compared with the placebo groups (−0.56 mmol/l (95% CI, −1.10 to −0.01); P for heterogeneity = 0.02). The difference in post‐intervention HbA1c between magnesium supplementation groups and control groups was not significant (−0.31% (95% CI, −0.81 to 0.19); P for heterogeneity = 0.10). Neither systolic nor diastolic BP was significantly changed. Magnesium supplementation increased on high‐density lipoprotein (HDL) cholesterol levels (0.08 mmol/l (95% CI, 0.03 to 0.14); P for heterogeneity = 0.36) but had no effect on total cholesterol, low‐density lipoprotein (LDL) cholesterol and triglyceride. Conclusions Oral magnesium supplementation for 4–16 weeks may be effective in reducing plasma fasting glucose levels and raising HDL cholesterol in patients with Type 2 diabetes, although the long‐term benefits and safety of magnesium treatment on glycaemic control remain to be determined. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetic Medicine Wiley

Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta‐analysis of randomized double‐blind controlled trials

Loading next page...
 
/lp/wiley/effects-of-oral-magnesium-supplementation-on-glycaemic-control-in-type-UM1Alrzg8j
Publisher
Wiley
Copyright
Copyright © 2006 Wiley Subscription Services, Inc., A Wiley Company
ISSN
0742-3071
eISSN
1464-5491
D.O.I.
10.1111/j.1464-5491.2006.01852.x
Publisher site
See Article on Publisher Site

Abstract

Aims The aim of this study was to assess the evidence on the effect of oral magnesium supplementation on glycaemic control in patients with Type 2 diabetes. Methods We searched the electronic databases of medline, embase and the Cochrane Controlled Trials Register up to January 2005. We identified nine randomized double‐blind controlled trials with a total of 370 patients with Type 2 diabetes and of duration 4–16 weeks. The median dose of oral magnesium supplementation was 15 mmol/day (360 mg/day) in the treatment groups. The primary outcome was glycaemic control, as measured by glycated haemoglobin (HbA1c) or fasting blood glucose levels; the secondary outcomes included body mass index, blood pressure (BP) and lipids. Using a random‐effects model, we calculated the weighted mean differences (WMD) and 95% confidence interval (CI). Results After a median duration of 12 weeks, the weighted mean post‐intervention fasting glucose was significantly lower in the treatment groups compared with the placebo groups (−0.56 mmol/l (95% CI, −1.10 to −0.01); P for heterogeneity = 0.02). The difference in post‐intervention HbA1c between magnesium supplementation groups and control groups was not significant (−0.31% (95% CI, −0.81 to 0.19); P for heterogeneity = 0.10). Neither systolic nor diastolic BP was significantly changed. Magnesium supplementation increased on high‐density lipoprotein (HDL) cholesterol levels (0.08 mmol/l (95% CI, 0.03 to 0.14); P for heterogeneity = 0.36) but had no effect on total cholesterol, low‐density lipoprotein (LDL) cholesterol and triglyceride. Conclusions Oral magnesium supplementation for 4–16 weeks may be effective in reducing plasma fasting glucose levels and raising HDL cholesterol in patients with Type 2 diabetes, although the long‐term benefits and safety of magnesium treatment on glycaemic control remain to be determined.

Journal

Diabetic MedicineWiley

Published: Oct 1, 2006

References

  • Role of magnesium in insulin action, diabetes and cardio–metabolic syndrome X
    Barbagallo, Barbagallo; Dominguez, Dominguez; Galioto, Galioto; Ferlisi, Ferlisi; Cani, Cani; Malfa, Malfa
  • Role of magnesium in the pathogenesis of hypertension
    Touyz, Touyz
  • Protective role of magnesium in cardiovascular diseases: a review
    Chakraborti, Chakraborti; Chakraborti, Chakraborti; Mandal, Mandal; Mandal, Mandal; Das, Das; Ghosh, Ghosh

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off